Britain approves Novavax COVID-19 shot for 12-17 year-olds (Photo: Reuters)Britain approves Novavax COVID-19 shot for 12-17 year-olds (Photo: Reuters)Britain's medicines regulator on Friday approved Novavax's COVID-19 vaccine for children aged between 12 and 17 years.
The mRNA vaccines made by Moderna as well as the partnership between Pfizer-BioNTech are also cleared for use by this age group, the Medicines and Healthcare products Regulatory Agency (MHRA) said.
Britain in February cleared Novavax's two-dose vaccine, Nuvaxovid, for use in adults.
Bharti Airtel falls 3% on large block deal, logs Rs 15,000 crore turnover on NSE
IndusInd Bank shares crack 6% on MFI portfolio discrepancy, stage recovery 
JSW Energy Q4 earnings: Fund raising, dividend, net profit, share price and more 
'Dono haathon mein laddu': After Trump's request to Tim Cook, CA says India only has gains to book
‘Scary numbers’: Zerodha’s Nithin Kamath flags a crisis India is ignoring at its own peril
Aamir Khan Faces Backlash Over Erdogan Meet | Boycott Calls Hit New Film Release
India Boots Turkish Airport Services Operator Over Security Threat | Celebi's Services Cancelled
Trump Pressures India On Trade, Tariffs & Apple | Big Trumponomics Dose Ahead Of Negotiations
Despite India’s Earthquake Relief, Turkey Sides With Pakistan; Indians Launch Massive Boycott
Sneak Peek Of SkyStriker Drones India Used In Operation Sindoor To Rain Fire On Pakistan
PB Fintech shares rise 4% as net profit more than doubles in Q4
Railway stock RITES up 8% today; key triggers, price targets post Q4 results
Kaynes Technology shares jump 9% on strong Q4 FY25 numbersBharti Airtel falls 3% on large block deal, logs Rs 15,000 crore turnover on NSEIndusInd Bank shares crack 6% on MFI portfolio discrepancy, stage recovery 